Nanoparticles as therapeutic options for treating multidrug-resistant bacteria: research progress, challenges, and...

Area of Science:

• Biomaterials Science
• Nanotechnology
• Microbiology

Background:

• Antimicrobial resistance (AMR) is a significant global public health threat, driven by multidrug-resistant microbes and a lack of new effective antimicrobial drugs.
• The WHO highlights the alarming rise in infections caused by resistant pathogens, leading to increased morbidity and mortality.
• Novel therapeutic strategies are urgently needed to combat the growing challenge of antimicrobial resistance.

Purpose of the Study:

• To review the current insights into antimicrobial resistance mechanisms.
• To explore the antibacterial activity of various nanoparticles, with a focus on metals and metal oxides.
• To discuss the application of nanomaterials in photothermal therapy and drug delivery for combating resistant infections.

Main Methods:

• Literature review of recent findings on nanomaterials against multi-resistant pathogenic bacteria.
• Analysis of nanoparticle antibacterial mechanisms and photothermal therapy applications.
• Discussion of synergistic interactions, microbial adaptation, challenges, and future prospects.

Main Results:

• Nanoparticles, particularly metal and metal oxide types, are emerging as promising therapeutic agents against drug-resistant microbes.
• Photothermal therapy using nanomaterials offers a light-activated strategy for microbial killing and enhanced drug delivery.
• Synergistic effects of nanoparticles with antibiotics and other nanomaterials show potential for overcoming resistance.

Conclusions:

• Nanomaterials represent a viable therapeutic option for treating drug-resistant infections, offering novel mechanisms of action.
• Further research into nanoparticle-based therapies, including photothermal applications and synergistic combinations, is crucial for addressing the AMR crisis.
• Understanding microbial adaptation to nanoparticles and overcoming current challenges will pave the way for future clinical applications.